Search research articles
Contact Us
Filters
Showing results (111-120 of 225) with videos related to
Page
of 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Matthew S Davids, Bryone J Kuss, Peter Hillmen, et al.
Blood
|
April 10, 2025
ZUMA-8: A Phase 1 Study of Brexucabtagene Autoleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Matthew S Davids, Saad S Kenderian, Ian W Flinn, et al.
Leukemia
|
June 23, 2025
Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia
Kiyomi Mashima, Yanan Kuang, Stacey M Fernandes, et al.
Blood Advances
|
January 4, 2018
Early progression of disease as a predictor of survival in chronic lymphocytic leukemia
Inhye E Ahn, Charles M Farber, Matthew S Davids, et al.
Blood Advances
|
June 23, 2026
SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL
Jennifer L Crombie, Inhye E Ahn, Yue Ren, et al.
Ejhaem
|
July 18, 2022
Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect<sup>®</sup> CLL Registry
Jeff P Sharman, Kim Cocks, Chadi Nabhan, et al.
Blood Cancer Journal
|
February 2, 2023
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, et al.
British Journal of Haematology
|
January 6, 2016
A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma
Philippe Armand, Robert Redd, Jad Bsat, et al.
Haematologica
|
July 3, 2025
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial
Geoffrey Shouse, Canping Chen, Alexandra Muir, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 21, 2018
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry
Anthony Mato, Chadi Nabhan, Neil E Kay, et al.
Page
of 23
Search research articles
Search
Showing results (111-120 of 225) with videos related to
Sort By:
Page
of 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Matthew S Davids, Bryone J Kuss, Peter Hillmen, et al.
Blood
|
April 10, 2025
ZUMA-8: A Phase 1 Study of Brexucabtagene Autoleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Matthew S Davids, Saad S Kenderian, Ian W Flinn, et al.
Leukemia
|
June 23, 2025
Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia
Kiyomi Mashima, Yanan Kuang, Stacey M Fernandes, et al.
Blood Advances
|
January 4, 2018
Early progression of disease as a predictor of survival in chronic lymphocytic leukemia
Inhye E Ahn, Charles M Farber, Matthew S Davids, et al.
Blood Advances
|
June 23, 2026
SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL
Jennifer L Crombie, Inhye E Ahn, Yue Ren, et al.
Ejhaem
|
July 18, 2022
Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect<sup>®</sup> CLL Registry
Jeff P Sharman, Kim Cocks, Chadi Nabhan, et al.
Blood Cancer Journal
|
February 2, 2023
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors
Deepti Gadi, Stephen P Martindale, Pui Yan Chiu, et al.
British Journal of Haematology
|
January 6, 2016
A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma
Philippe Armand, Robert Redd, Jad Bsat, et al.
Haematologica
|
July 3, 2025
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial
Geoffrey Shouse, Canping Chen, Alexandra Muir, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 21, 2018
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry
Anthony Mato, Chadi Nabhan, Neil E Kay, et al.
Page
of 23